Combination of rituximab and chemotherapy showing anti-tumor effect in gamma heavy chain disease expressing CD20

Am J Hematol. 2008 Dec;83(12):938-9. doi: 10.1002/ajh.21284.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20 / immunology*
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Cyclophosphamide / administration & dosage
  • Etoposide / administration & dosage
  • Fatal Outcome
  • Heavy Chain Disease / drug therapy
  • Humans
  • Immunoglobulin gamma-Chains*
  • Male
  • Prednisone / administration & dosage
  • Procarbazine / administration & dosage
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20
  • Immunoglobulin gamma-Chains
  • Procarbazine
  • Rituximab
  • Etoposide
  • Cyclophosphamide
  • Prednisone